] i transients were measured simultaneously using a video-based edge detection and dual excitation fluorescence photomultiplier system. Results: Ketamine (20, 40, 80 μmol/L) inhibited I NaL in a concentration-dependent manner. In the presence of sea anemone toxin II (ATX, 30 nmol/L), I NaL was augmented by more than 3-fold, while ketamine concentration-dependently suppressed the ATX-augmented I NaL . Ketamine (40 μmol/L) also significantly suppressed hypoxia or H 2 O 2 -induced enhancement of I NaL . Furthermore, ketamine concentration-dependently attenuated ATX-induced enhancement of reverse-mode I NCX . In addition, ketamine (40 μmol/L) inhibited I CaL by 33.4%. In the presence of ATX (3 nmol/L), the rate and amplitude of cell shortening and relaxation, the diastolic [Ca 2+ ] i , and the rate and amplitude of [Ca 2+ ] i rise and decay were significantly increased, which were reverted to control levels by tetrodotoxin (TTX, 2 μmol/L) or by ketamine (40 μmol/L). Conclusion: Ketamine protects isolated rabbit ventricular myocytes against [Ca 2+ ] i overload by inhibiting I NaL and I CaL .
Introduction
Cardiomyocyte Ca 2+ overload occurs in many pathological conditions such as hypoxia, ischemia, oxidative stress, cardiac hypertrophy, and heart failure [1] [2] [3] [4] . Intracellular Ca 2+ ([Ca 2+ ] i ) overload causes cardiac arrhythmias and myocardial dysfunction [5] . Extensive reports show that the late or persistent sodium current (I NaL ) in ventricular myocytes is increased in many pathological conditions that lead to [Ca 2+ ] i overload [6] [7] [8] [9] [10] . An increase in the amplitude of I NaL prolongs the action potential duration, increases the transmural dispersion of repolarization, and causes cardiac arrhythmias [11] . An increase in I NaL also increases the intracellular sodium concentration and subsequently raises [Ca 2+ ] i via the reverse-mode Na + -Ca 2+ exchanger (NCX) [7, 12] . Inhibition of I NaL was reported to attenuate the increase in [Ca 2+ ] i [13] [14] [15] . Inhibition of I NaL is therefore a potential therapeutic target for the treatment of heart diseases associated with [Ca 2+ ] i overload [16, 17] . Ketamine is an intravenous and intramuscular anesthetic that is widely used in both humans and animals. In vitro study data show that ketamine has antiarrhythmic effects and decreases the incidence of reperfusion-induced arrhythmias [18] [19] [20] [21] and that it enhances the recovery of force of contraction during reperfusion [22] . Furthermore, ketamine suppresses the activity of neutrophils and decreases their postischemic adhesion in the coronary artery [23] [24] [25] . In clinical studies, ketamine has reduced the incidence of ventricular arrhythmias and clinical markers of myocardial injury in cardiac surgery patients [26] [27] [28] . These results suggest that ketamine may have cardioprotective effects, but the underlying mechanisms are still unknown. Ketamine has been reported to inhibit various ionic currents, including the L-type Ca 2+ current (I CaL ) [29] [30] [31] [32] [33] [34] , peak sodium current (I Na ) [32] , inward rectifier K + current (I K1 ) [30, 35] , delayed rectifier K + current (I K ) [30] , ATP-sensitive K + current (I KATP ) [36, 37] , and human ether-a-go-go-related gene (hERG) channel [38] . However, there is no study regarding the effects of ketamine on I NaL . In previous studies, we found that inhibition of I NaL attenuates augmented I NaL -induced [Ca 2+ ] i overload [39, 40] . Thus, this study investigated the effects of ketamine on I NaL , the NCX current (I NCX ), myocyte shortening and [Ca 2+ ] i transients in the presence of sea anemone toxin II (ATX), an opener of I NaL channels. Myocytes were isolated enzymatically from the hearts of rabbits of both sexes (1.7-2 kg; Wuhan Institute of Biological Products Co, Ltd, Wuhan, China), as previously described [41] . In brief, adult New Zealand white rabbits were heparinized (2000 U) and anesthetized with ketamine (iv; 30 mg/kg) and xylazine (im; 7.5 mg/kg). Hearts were quickly excised and retrogradely perfused with Ca 2+ -free Tyrode's solution for 5 min, followed by an enzyme-containing solution (0.1 g/L collagenase type I, 0.01 g/L protease E and 0.5 g/L bovine serum albumin) for a further 40-50 min. The perfusate was finally switched to KB solution for 5 min. All solutions were bubbled with 100% O 2 and maintained at 37 °C. The left ventricle was cut into small chunks and gently agitated in KB solution. The cells were filtered through nylon mesh and stored in KB solution at 4 °C until used. 4 ). For the hypoxia experiment, the modified bath solution in which glucose was omitted was pre-equilibrated with 100% N 2 for at least 1 h. Hypoxia was induced using a previously described method [42] . 
Materials and methods

Isolation of ventricular myocytes
Solution
Current recordings
All experiments were conducted at 22-25 °C. The electrode resistance (when filled with pipette solution) was 1.5-2 MΩ. Cell capacitance and series resistances were electronically compensated by 60%-80%. Currents were recorded using an EPC-9 amplifier (HEKA Electronic, Lambrecht, Pfalz, Germany), filtered at 2 kHz and sampled at 10 kHz. Current measurements were normalized using the cell capacitance.
I NaL was recorded by a 300-ms depolarizing pulse to -20 mV from a holding potential of -120 at a frequency of 0.2 Hz. The amplitude of I NaL was determined from the average current measured during a time interval of 190 to 210 ms after initiation of the depolarizing pulse to eliminate any contribution of I Na [2] . To record the current-voltage relationship of I NaL , 300-ms depolarizing pulses to membrane potentials from −80 to +50 mV were applied at 0.5 Hz from a potential of −120 mV.
I NCX was elicited by a 10-ms prepulse to +60 mV from a holding potential of −40 mV followed by a 2-s ramp pulse from +60 to −120 mV (with a speed of -90 mV/s). I NCX was measured as the current sensitive to 5 mmol/L Ni 2+ at +50 and -100 mV. I CaL was elicited by a 150-ms prepulse to −40 mV from a holding potential of −80 mV followed by a 300-ms depolarizing pulse from −40 mV to 0 mV (0.2 Hz). I CaL was measured as the difference between peak inward current and the current remaining at the end of the 300-ms pulse.
Measurements of myocyte cell shortening and [Ca 2+ ] i transients Fura-2 was loaded by incubating cell suspensions with 1 μmol/L Fura-2/AM for 30 min at 25 °C in the dark. Fura-2-loaded myocytes mounted in a chamber situated on the stage of an Olympus IX-70 inverted microscope were field stimulated to contract between platinum electrodes (0.5 Hz, 37 °C). Cardiomyocytes that possessed an appropriate morphological appearance (rod shaped with clean edges, clear striations, and no large blebs), a resting sarcomere length >1.70 μm, and no spontaneous contraction was selected for experimentation. 
Statistical analysis
The data are expressed as the mean±SD. A paired Student's t-test was performed for comparisons between two groups. Statistical analysis was performed using repeated measures analysis of variance (ANOVA), followed by the Scheffé test for multiple comparisons. Statistical analyses were performed using Origin software v7.0 (OriginLab, Northampton, MA). All statistical tests were two-tailed. A value of P<0.05 was considered statistically significant.
Results
Ketamine inhibited I NaL in rabbit ventricular myocytes in a concentration-dependent manner The whole-cell patch-clamp technique was used to record I NaL . Ketamine (20, 40 , 80 μmol/L) decreased the current density of I NaL from 0.34±0.08 to 0.28±0.08, 0.22±0.07, and 0.14±0.06 pA/pF (P<0.01 vs control for all; n=11) in a concentrationdependent manner, respectively (Figure 1 ). This inhibitory effect of ketamine was reversible upon washout (0.34±0.09 vs 0.33±0.11 pA/pF, P>0.05, n=6). Figures 1A and 1B show the representative current records and summary data for the I NaL current density.
Effect of ketamine on ATX-augmented I NaL The I NaL channel opener ATX (30 nmol/L) increased I NaL (at -20 mV) from 0.29±0.01 to 1.23±0.05 pA/pF (P<0.01; n=8). In the presence of ATX, ketamine (20, 40 , 80 μmol/L) decreased it to 1.09±0.08, 0.88±0.08, and 0.72±0.06 pA/pF (P<0.01 vs ATX for all; n=8) in a concentration-dependent manner, respectively (Figure 2) . Figures 2A and 2B show the original current records and current-voltage curves of I NaL according to the current-voltage relationship protocol, respectively. Figure 2C shows the summary data for the I NaL current density recorded at -20 mV.
Effect of ketamine on the enhanced I NaL induced by hypoxia or H 2 O 2 Previous reports show that I NaL is increased under hypoxia and oxidative stress conditions. Thus, we studied the effects of ketamine on I NaL after exposure to hypoxia or H 2 O 2 . Hypoxia ] i /dt were increased to 160%, 180%, 191%, 114%, 165%, 159%, and 162% of control, respectively, and TD 90 was decreased to 82% of control by ATX (P<0.01 vs control for all; n=7). In the presence of ATX, TTX (2 μmol/L) reverted these measures to 99%, 97%, 101%, 100%, 104%, 98%, 106%, and 98% of control, respectively (P>0.05 vs control for all; Figure 5 ). Similarly, ketamine (40 μmol/L) reverted the above parameters from 169% to 99%, 169% to 99%, 224% to 114%, 110% to 99%, 165% to 104%, 159% to 98%, 162% to 106%, and 82% to 98% of control, respectively (n=7, P<0.01 ATX vs ketamine group for all; Figure 6 ). ] i transients. Previous studies show that ketamine inhibits I CaL in the cardiomyocytes of some species [29] [30] [31] [32] [33] [34] . However, no studies have investigated the effect of ketamine on I CaL in rabbit ventricular myocytes. The effect of ketamine on I CaL could be attributed to ketamine's suppressive effect on myocyte shortening in this study. Thus, in this study, we examined the effect of ketamine on I CaL and observed that ketamine (40 μmol/L) significantly inhibited I CaL in rabbit ventricular myocytes. The current density of I CaL was decreased from 4.41±1.15 to 2.94±1.06 pA/pF (P<0.01, n=9; Figure 7 ). After washing, I CaL returned to the predrug control level (4.65±0.74 vs 4.54±0.67 pA/pF, P>0.05, n=3).
Discussion
Cardiomyocyte [Ca 2+ ] i overload occurs in many pathological conditions such as hypoxia, ischemia, oxidative stress, cardiac hypertrophy, and heart failure [1] [2] [3] [4] and results in cardiac arrhythmias and myocardial dysfunction [5] . Previous reports show that I NaL is an important contributing factor to [Ca 2+ ] i overload in many pathological conditions. An increase in I NaL ] i through reverse NCX [7, 12] . Extensive studies have reported that inhibition of I NaL attenuates the increase in [Ca 2+ ] i [13] [14] [15] . Inhibition of I NaL is therefore a potential therapeutic target for the treatment of heart diseases associated with [Ca 2+ ] i overload [16, 17] . Ketamine is an intravenous and intramuscular anesthetic that is widely used in pediatric and adult cardiac surgery. In clinical studies, the serum concentrations of ketamine reach 60 µmol/L 5 min after an intravenous administration of 2 mg/kg [43] . The protein binding of ketamine is 12%-50% [44, 48] , and thus, the free concentration of ketamine may reach 30-50 µmol/L at 5 min. However, greater plasma concentrations can be expected at 1-3 min after induction and may reach 100-150 µmol/L. Therefore, our experimental concentrations (20-80 µmol/L) appear likely to be within the clinical range.
Ketamine has been reported to inhibit various ionic currents [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] . Hara et al reported that ketamine (30, 100, 300 μmol/L) dose-dependently blocked peak I Na in guinea pig ventricular myocytes [32] . However, no studies have investigated the effects of ketamine on I NaL in cardiomyocytes until now. In this study, we found that ketamine inhibited control and the enhanced I NaL induced by ATX, hypoxia, or H 2 O 2 (Figures 1-3) . The inhibitory effect of ketamine was reversible (Figures 1, 3) . In our present and previous studies [39] , the ATX-augmented reverse-mode I NCX , myocyte shortening and [Ca 2+ ] i transients were reversed completely by TTX (Figures 4-5) , which shows that an increase in I NaL causes these changes. The inhibition of I NaL is predicted to reverse the ATX-induced changes described above. Consistent with this hypothesis, ketamine inhibited ATX-augmented reverse I NCX , myocyte shortening and [Ca 2+ ] i overload (Figures 4, 6 ). This result is similar to that obtained in our previous reports, which describe the inhibition of reverse I NCX by sophocarpine and resveratrol, cell shortening and [Ca 2+ ] i overload by inhibiting I NaL [39, 40] . Therefore, the inhibition of I NaL contributes to ketamine's suppressive effects on [Ca 2+ ] i transients and myocyte shortening. In this study, we observed an interesting phenomenon: ketamine partly inhibited ATX-augmented I NaL and I NCX ( Figures  2, 4) but completely, although partly not expectedly, reversed the changes in [Ca 2+ ] i transients and myocyte shortening induced by ATX (Figure 6 ). This result shows that there are additional mechanisms other than inhibiting I NaL underlying ketamine's suppressive effects. Previous studies show npg that ketamine inhibits I CaL in guinea pig and rat ventricular myocytes, in human right atrial myocytes and bullfrog atrial myocytes [29] [30] [31] [32] [33] [34] . Hara et al reported that ketamine (30 μmol/L) decreased I CaL by 26.1% in guinea pig ventricular myocytes [32] . Endou et al reported that ketamine (100 μmol/L) decreased I CaL by 10.8% in rat ventricular myocytes [30] . However, no study had yet investigated the effect of ketamine on I CaL in rabbit ventricular myocytes. In this study, 40 μmol/L ketamine, a concentration used in our myocyte shortening and [Ca 2+ ] i transient recordings, inhibited I CaL by 33.4% in rabbit ventricular myocytes (Figure 7) , which is similar to the findings of Hara et al [32] but different from those of Endou et al [30] . These discrepancies seem to originate from the species differences. The present result suggested that the inhibition of I CaL could also contribute to ketamine's suppressive effects on [Ca 2+ ] i transients and myocyte shortening.
Extensive studies demonstrate that perioperative myocardial ischemia is common and is associated with serious cardiac morbidities and mortality. Its incidence in noncardiac surgery patients at risk of or with known coronary artery disease is 20%-63% [46] . The incidence of intraoperative myocardial ischemia in patients undergoing coronary artery bypass grafting surgery is 26%-78% [47] . A previous report has shown that hypoxia (8 min) increases I NaL and reverses I NCX in rabbit ventricular myocytes [42] , which suggests an increase in [Ca 2+ ] i at that time. Furthermore, a burst of H 2 O 2 is generated in car- diomyocytes during ischemia, and H 2 O 2 also increases I NaL in cardiomyocytes. As such, cardiomyocyte [Ca 2+ ] i overload will probably occur in the perioperative period.
Ketamine is widely used in pediatric and adult cardiac surgery. Previous studies show that ketamine has antiarrhythmic effects and decreases the incidence of reperfusion-induced arrhythmias in animal models [18] [19] [20] [21] . Hanouz et al reported that ketamine preconditions human myocardium and enhances the recovery of force of contraction during reperfusion [22] . Furthermore, ketamine has been shown to suppress the activity of neutrophils and decrease their postischemic adhesion in the coronary artery in in vitro studies [23] [24] [25] . In clinical studies, ketamine has reduced the incidence of ventricular arrhythmias and clinical markers of myocardial injury in cardiac surgery patients [26] [27] [28] . These results suggest that ketamine may have cardioprotective effects. In this study, ketamine inhibited the augmented I NaL induced by hypoxia and H 2 O 2 ( Figure 3 ) and attenuated the augmented I NaL -induced [Ca 2+ ] i overload (Figure 6) . Therefore, ketamine could protect the heart against ischemia/reperfusion injury in the perioperative period by preventing [ 
Author contribution
An-tao LUO, Zhen-zhen CAO, and Ji-hua MA designed the research; An-tao LUO, Zhen-zhen CAO, Yu XIANG, Shuo 
